- Home
- MOGU vs MYNZ Comparison
MOGU vs MYNZ Comparison
Compare MOGU & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- MYNZ
- Stock Information
- Founded
- MOGU 2011
- MYNZ 2021
- Country
- MOGU China
- MYNZ Germany
- Employees
- MOGU N/A
- MYNZ N/A
- Industry
- MOGU Business Services
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- MOGU Consumer Discretionary
- MYNZ Health Care
- Exchange
- MOGU Nasdaq
- MYNZ Nasdaq
- Market Cap
- MOGU 19.1M
- MYNZ 12.8M
- IPO Year
- MOGU 2018
- MYNZ 2021
- Fundamental
- Price
- MOGU $1.90
- MYNZ $4.80
- Analyst Decision
- MOGU
- MYNZ Buy
- Analyst Count
- MOGU 0
- MYNZ 3
- Target Price
- MOGU N/A
- MYNZ $14.00
- AVG Volume (30 Days)
- MOGU 9.7K
- MYNZ 253.2K
- Earning Date
- MOGU 11-22-2024
- MYNZ 04-15-2025
- Dividend Yield
- MOGU N/A
- MYNZ N/A
- EPS Growth
- MOGU N/A
- MYNZ N/A
- EPS
- MOGU N/A
- MYNZ N/A
- Revenue
- MOGU $19,801,126.00
- MYNZ $917,203.00
- Revenue This Year
- MOGU N/A
- MYNZ $20.94
- Revenue Next Year
- MOGU N/A
- MYNZ $18.01
- P/E Ratio
- MOGU N/A
- MYNZ N/A
- Revenue Growth
- MOGU N/A
- MYNZ 16.23
- 52 Week Low
- MOGU $1.62
- MYNZ $0.18
- 52 Week High
- MOGU $3.58
- MYNZ $8.20
- Technical
- Relative Strength Index (RSI)
- MOGU 36.71
- MYNZ 44.33
- Support Level
- MOGU $1.87
- MYNZ $4.14
- Resistance Level
- MOGU $2.40
- MYNZ $5.62
- Average True Range (ATR)
- MOGU 0.13
- MYNZ 0.64
- MACD
- MOGU -0.03
- MYNZ -0.12
- Stochastic Oscillator
- MOGU 10.34
- MYNZ 37.67
About MOGU MOGU Inc. (each representing 25)
MOGU Inc is an online fashion and lifestyle destination in China. The company's online platform includes Mogu.com, Mogujie.com, and Meilishuo.com. Its platform allows people to discover and share fashion trends while fully enjoying the shopping experience. The company on its platform provides content related to fashion and lifestyle guides in various multi-media formats which include Live Video Broadcasts, Short-form Videos, Photography, and Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology and other relevant services to merchants and users as well as technology services to brands owners.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.